NovoCure (NVCR) EPS (Basic) Growth (3y) (2017 - 2026)
NovoCure (NVCR) EPS (Basic) Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.17 Bn | 175.87 Bn | 6.27 Bn | -6.52% |
| 2 | Stryker | 129.06 Bn | 126.18 Bn | 3.81 Bn | 7.60% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | 62.89% |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 60.34% |
| 7 | GE HealthCare Technologies | 28.08 Bn | 25.80 Bn | 1.98 Bn | 29.37% |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 30.65% |
| 10 | NovoCure | 2.01 Bn | 1.57 Bn | 142.48 Mn | 37.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.02% |
| Mar 31, 2026 | -7.46% |
| Dec 31, 2025 | 14.88% |
| Sep 30, 2025 | -9.54% |
| Jun 30, 2025 | -16.17% |
| Mar 31, 2025 | -91.08% |
| Dec 31, 2024 | -33.70% |
| Sep 30, 2024 | -30.69% |
| Jun 30, 2024 | -29.87% |
| Mar 31, 2024 | -107.89% |
| Dec 31, 2023 | -122.96% |
| Sep 30, 2023 | -91.78% |
| Jun 30, 2023 | -226.72% |
| Mar 31, 2023 | -144.91% |
| Dec 31, 2022 | -116.41% |
| Sep 30, 2022 | -146.24% |
| Jun 30, 2022 | -159.18% |
| Mar 31, 2022 | 29.66% |
| Dec 31, 2021 | -14.54% |
| Sep 30, 2021 | -0.17% |